The Anti-CCP antibody (Anti–Cyclic Citrullinated Peptide) test is a blood test used to help diagnose rheumatoid arthritis (RA), an autoimmune disease in which the immune system mistakenly attacks the joints. The test looks for anti-CCP antibodies (also called ACPA), which are immune proteins that can target citrullinated proteins—proteins that have undergone a natural change in the body during inflammation.

This is considered a highly specific test for rheumatoid arthritis. In plain language, that means a positive Anti-CCP result is strongly suggestive of RA (especially when symptoms fit), and it can be helpful for identifying RA early, sometimes even before joint damage is visible on X-rays. It may also provide prognostic information: people with higher Anti-CCP levels are more likely to have more persistent or erosive (joint-damaging) disease.

How results are generally interpreted (your lab’s reference range may vary):

Negative/normal: Anti-CCP antibodies are not detected or are below the lab cutoff. This makes RA less likely, but it does not completely rule it out because some people have “seronegative” rheumatoid arthritis (negative Anti-CCP and sometimes negative rheumatoid factor as well).

Positive: Anti-CCP antibodies are detected. This significantly increases the likelihood of rheumatoid arthritis, particularly if you have typical symptoms (joint swelling, morning stiffness, symmetrical small-joint pain). Higher titers (levels) can be associated with higher risk of developing RA or more aggressive disease, but results must be interpreted alongside symptoms, exam findings, imaging, and other labs (such as rheumatoid factor (RF), ESR, and CRP).

Doctors commonly order the Anti-CCP antibody test when rheumatoid arthritis is suspected or when they want to better understand the likelihood and potential course of inflammatory arthritis. It is especially useful in early rheumatoid arthritis—when symptoms are present but the diagnosis is not yet clear.

This test may be recommended if you have symptoms such as:

• Joint pain and swelling, especially in the hands, wrists, or feet
• Morning stiffness lasting 30–60 minutes or longer that improves with movement
• Symmetrical symptoms (same joints on both sides of the body)
• Warm, tender joints with decreased range of motion
• Fatigue, low-grade fever, or unintentional weight loss (sometimes seen with active inflammation)

It may also be ordered if:

• Rheumatoid factor (RF) is negative but RA is still suspected (Anti-CCP can be positive when RF is not).
• You have undifferentiated inflammatory arthritis and your clinician is assessing the risk of developing definite rheumatoid arthritis.
• Your clinician wants prognostic information to guide treatment decisions (for example, the urgency of starting disease-modifying antirheumatic drugs, or DMARDs).
• There is concern for joint damage progression and the care team is evaluating overall risk alongside imaging and inflammatory markers.

Because rheumatoid arthritis can cause permanent joint damage, early diagnosis and treatment are important. Anti-CCP testing helps support faster, more confident decision-making when RA is part of the differential diagnosis.

• Rheumatoid arthritis (RA)
• Early rheumatoid arthritis / preclinical RA (risk assessment when symptoms suggest inflammatory arthritis)
• Seronegative inflammatory arthritis (RA may still be considered even if Anti-CCP is negative, depending on the clinical picture)
• Other autoimmune or inflammatory joint conditions that may be evaluated in the differential diagnosis (e.g., psoriatic arthritis, lupus-related arthritis)

• Supporting early diagnosis of rheumatoid arthritis to reduce the risk of long-term joint damage
• Clarifying the cause of persistent joint pain, swelling, and morning stiffness
• Assessing prognosis (risk of more persistent or erosive RA) to help guide timely treatment planning
• Improving long-term joint function and quality of life through earlier identification of inflammatory arthritis
• Monitoring overall autoimmune and inflammation evaluation alongside related tests (RF, ESR, CRP) as part of a comprehensive workup